These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 8035320
21. Characterization of receptors for two Xenopus gastrointestinal tachykinin peptides in their species of origin. Johansson A, Liu L, Holmgren S, Burcher E. Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):35-45. PubMed ID: 15235762 [Abstract] [Full Text] [Related]
22. The contractile effect of tachykinins on human prostatic urethra: involvement of NK-2 receptors. Parlani M, Conte B, Majmone S, Maggi CA, Rovero P, Giachetti A. J Urol; 1990 Dec; 144(6):1543-5. PubMed ID: 2172570 [Abstract] [Full Text] [Related]
23. Tachykinin receptors are involved in the "local efferent" motor response to capsaicin in the guinea-pig small intestine and oesophagus. Barthó L, Lénárd L, Patacchini R, Halmai V, Wilhelm M, Holzer P, Maggi CA. Neuroscience; 1999 Apr; 90(1):221-8. PubMed ID: 10188948 [Abstract] [Full Text] [Related]
24. Pharmacological examination of receptors mediating contractile responses to tachykinins in airways isolated from human, guinea pig and hamster. Ellis JL, Undem BJ, Kays JS, Ghanekar SV, Barthlow HG, Buckner CK. J Pharmacol Exp Ther; 1993 Oct; 267(1):95-101. PubMed ID: 8229792 [Abstract] [Full Text] [Related]
25. Role of nitric oxide and septide-insensitive NK(1) receptors in bronchoconstriction induced by aerosolised neurokinin A in guinea-pigs. Ricciardolo FL, Trevisani M, Geppetti P, Nadel JA, Amadesi S, Bertrand C. Br J Pharmacol; 2000 Mar; 129(5):915-20. PubMed ID: 10696090 [Abstract] [Full Text] [Related]
26. Competitive antagonists discriminate between NK2 tachykinin receptor subtypes. Maggi CA, Patacchini R, Giuliani S, Rovero P, Dion S, Regoli D, Giachetti A, Meli A. Br J Pharmacol; 1990 Jul; 100(3):589-92. PubMed ID: 2167737 [Abstract] [Full Text] [Related]
27. SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist. Anthes JC, Chapman RW, Richard C, Eckel S, Corboz M, Hey JA, Fernandez X, Greenfeder S, McLeod R, Sehring S, Rizzo C, Crawley Y, Shih NY, Piwinski J, Reichard G, Ting P, Carruthers N, Cuss FM, Billah M, Kreutner W, Egan RW. Eur J Pharmacol; 2002 Aug 23; 450(2):191-202. PubMed ID: 12206858 [Abstract] [Full Text] [Related]
28. Desensitization with a selective agonist discriminates between multiple tachykinin receptors. Laufer R, Gilon C, Chorev M, Selinger Z. J Pharmacol Exp Ther; 1988 May 23; 245(2):639-43. PubMed ID: 2835478 [Abstract] [Full Text] [Related]
29. A potent and selective agonist for NK-2 tachykinin receptor. Rovero P, Pestellini V, Patacchini R, Giuliani S, Santicioli P, Maggi CA, Meli A, Giachetti A. Peptides; 1989 May 23; 10(3):593-5. PubMed ID: 2550911 [Abstract] [Full Text] [Related]
30. Smooth muscle neurokinin-2 receptors mediate contraction in human saphenous veins. Mechiche H, Grassin-Delyle S, Pinto FM, Buenestado A, Candenas L, Devillier P. Pharmacol Res; 2011 May 23; 63(5):414-22. PubMed ID: 21272642 [Abstract] [Full Text] [Related]
35. The mechanisms for tachykinin-induced contractions of the rabbit corpus cavernosum. Takahashi R, Nishimura J, Hirano K, Naito S, Kanaide H. Br J Pharmacol; 2002 Nov 23; 137(6):845-54. PubMed ID: 12411416 [Abstract] [Full Text] [Related]